Tomohiro Iguchi Selected Research

ErbB Receptors (EGF Receptor)

1/2011	Immunohistochemical expression of epidermal growth factor receptor in breast cancer.
1/2009	A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohiro Iguchi Research Topics

Disease

52	Neoplasms (Cancer) 04/2022 - 05/2007
21	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 05/2007
10	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2009
8	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 06/2012
7	Lymphatic Metastasis 01/2016 - 03/2008
6	Stomach Neoplasms (Stomach Cancer) 12/2017 - 04/2011
6	Carcinoma (Carcinomatosis) 06/2015 - 02/2011
6	Cholangiocarcinoma 09/2010 - 07/2007
5	Carcinogenesis 09/2020 - 02/2009
5	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2014 - 08/2009
2	Sepsis (Septicemia) 07/2022 - 06/2021
2	Inflammation (Inflammations) 04/2022 - 02/2011
2	Pancreatic Fistula (Pancreatic Fistulas) 12/2021 - 01/2021
2	Liver Neoplasms (Liver Cancer) 10/2021 - 05/2007
2	Adenocarcinoma 09/2020 - 05/2010
2	Esophageal Squamous Cell Carcinoma 05/2020 - 09/2016
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2008
2	Infections 05/2014 - 12/2013
2	Liver Diseases (Liver Disease) 09/2010 - 04/2010
2	Fibrosis (Cirrhosis) 02/2010 - 11/2009
2	Hepatitis C 11/2009 - 01/2009
1	Cholecystitis 07/2022
1	Pneumonia (Pneumonitis) 07/2022
1	COVID-19 07/2022
1	Abdominal Pain (Pain, Abdominal) 07/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Delirium 06/2021
1	Hemorrhage 06/2021
1	Postoperative Hemorrhage 11/2020
1	Rupture 07/2020
1	Aggressive Fibromatosis (Desmoid) 02/2020
1	Wound Infection (Wound Infections) 12/2019
1	Cholelithiasis 01/2018
1	Liver Cell Adenoma (Hepatocellular Adenoma) 11/2016

Drug/Important Bio-Agent (IBA)

11	Indicators and Reagents (Reagents)IBA 04/2022 - 07/2007
8	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2016
8	Proteins (Proteins, Gene)FDA Link 12/2017 - 07/2007
7	Biological ProductsIBA 03/2017 - 05/2007
5	Messenger RNA (mRNA)IBA 01/2017 - 10/2014
4	Capsules (Microcapsules)IBA 10/2011 - 11/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 01/2014
3	MicroRNAs (MicroRNA)IBA 10/2017 - 01/2015
3	Long Noncoding RNAIBA 01/2017 - 03/2015
3	MucinsIBA 11/2011 - 05/2007
3	fascinIBA 12/2009 - 01/2009
2	AntigensIBA 07/2022 - 05/2010
2	Tumor Biomarkers (Tumor Markers)IBA 11/2020 - 09/2016
2	Calmodulin-Binding Proteins (Caldesmon)IBA 07/2020 - 06/2010
2	Transcription Factors (Transcription Factor)IBA 11/2016 - 04/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 09/2016
2	acarboxyprothrombin (PIVKA)IBA 11/2016 - 02/2009
2	EnzymesIBA 01/2016 - 07/2015
2	RhodaminesIBA 01/2016 - 07/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015 - 03/2015
2	Estrogen ReceptorsIBA 07/2015 - 01/2011
2	Fetal Proteins (Fetoprotein)IBA 06/2015 - 10/2011
2	SteroidsIBA 03/2014 - 12/2013
2	Capecitabine (Xeloda)FDA Link 07/2013 - 03/2011
2	C-Reactive ProteinIBA 04/2011 - 02/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 01/2009
2	InterferonsIBA 11/2009 - 01/2009
2	Cyclin B1IBA 01/2009 - 07/2007
1	Serum AlbuminIBA 04/2022
1	Gemcitabine FDA Link 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2021
1	lenvatinibIBA 10/2021
1	Sorafenib (BAY 43-9006)FDA Link 09/2020
1	8-Hydroxy-2'-DeoxyguanosineIBA 09/2020
1	atezolizumabIBA 09/2020
1	Bevacizumab (Avastin)FDA Link 09/2020
1	DNA Repair EnzymesIBA 09/2020
1	DesminIBA 07/2020
1	RNA Splicing FactorsIBA 05/2020
1	Ivermectin (Mectizan)FDA Link 12/2017
1	Antiparasitic Agents (Antiparasitics)IBA 12/2017
1	CXC ChemokinesIBA 01/2017
1	phosphoserine phosphataseIBA 01/2017
1	Discoidin Domain Receptor 2IBA 01/2017
1	CateninsIBA 11/2016
1	Genetic Markers (Genetic Marker)IBA 09/2016

Therapy/Procedure

9	Liver Transplantation 06/2015 - 02/2009
6	Therapeutics 07/2022 - 01/2009
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
2	Cholecystectomy 07/2022 - 01/2018
2	Splenectomy 01/2022 - 11/2014
2	Conservative Treatment 12/2021 - 01/2015
2	Neoadjuvant Therapy 12/2021 - 01/2018
2	Gastrectomy 07/2020 - 10/2012
2	Hepatectomy 01/2020 - 01/2011
2	Operative Time 09/2012 - 07/2012
1	Laparoscopic Cholecystectomy 07/2022
1	Nephrectomy 01/2022
1	Tracheostomy 06/2021
1	Stents 01/2021
1	Pancreaticoduodenectomy 01/2021
1	Segmental Mastectomy (Lumpectomy) 07/2020
1	Pancreatectomy 02/2020
1	Antibiotic Prophylaxis 12/2019